Connor, Clark & Lunn Investment Management (CC&L)’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.58M | Sell |
126,431
-50,458
| -29% | -$1.03M | 0.01% | 782 |
|
|
2025
Q1 | $3.54M | Buy |
176,889
+8,176
| +5% | +$164K | 0.02% | 588 |
|
|
2024
Q4 | $4.5M | Buy |
168,713
+3,255
| +2% | +$86.7K | 0.02% | 508 |
|
|
2024
Q3 | $4.72M | Buy |
165,458
+98,571
| +147% | +$2.81M | 0.02% | 447 |
|
|
2024
Q2 | $1.46M | Sell |
66,887
-10,770
| -14% | -$234K | 0.01% | 753 |
|
|
2024
Q1 | $1.72M | Sell |
77,657
-10,913
| -12% | -$242K | 0.01% | 720 |
|
|
2023
Q4 | $1.91M | Buy |
88,570
+7,985
| +10% | +$172K | 0.01% | 678 |
|
|
2023
Q3 | $1.36M | Buy |
80,585
+19,040
| +31% | +$322K | 0.01% | 726 |
|
|
2023
Q2 | $844K | Buy |
61,545
+19,363
| +46% | +$266K | ﹤0.01% | 847 |
|
|
2023
Q1 | $958K | Buy |
42,182
+14,038
| +50% | +$319K | 0.01% | 724 |
|
|
2022
Q4 | $663K | Buy |
28,144
+5,053
| +22% | +$119K | ﹤0.01% | 806 |
|
|
2022
Q3 | $602K | Buy |
23,091
+3,628
| +19% | +$94.6K | ﹤0.01% | 778 |
|
|
2022
Q2 | $427K | Buy |
+19,463
| New | +$427K | ﹤0.01% | 816 |
|